General MedicationsINJECTIONGeneric
GRANISETRON HYDROCHLORIDE
GRANISETRON HYDROCHLORIDE
Standard Dose
EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview GRANISETRON HYDROCHLORIDE is listed in Drugs@FDA under application 203454 (ANDA).
Marketing status: Discontinued Active ingredient GRANISETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2017-04-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview GRANISETRON HYDROCHLORIDE is listed in Drugs@FDA under application 203454 (ANDA). Marketing status: Discontinued Active ingredient GRANISETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2017-04-04 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.